Previous 10 | Next 10 |
Shares of micro-cap Rapid Micro Biosystems ( NASDAQ: RPID ) have surged ~37% to $4.36 in Thursday morning trading after a shareholder proposed a potential acquisition of the microbial contamination detection company. Kennedy Lewis Investment Management LLC, whose affilia...
Gainers: NeuroSense Therapeutics ( NRSN ) +53% . Rapid Micro Biosystems ( RPID ) +36% . Burning Rock Biotech ( BNR ) +15% . Tyra Biosciences ( TYRA ) +7% . Addex Therapeutics ( ADXN ) +5% . Losers: Renalytix ( RNLX ) -40% ...
Kennedy Lewis Investment Management LLC Announces Offer to Acquire Rapid Micro Biosystems PR Newswire NEW YORK , June 30, 2022 /PRNewswire/ -- Kennedy Lewis Investment Management LLC today sent the following letter to the Board of Directors of Rapid Micro...
Larry Robbins and Mark Horowitz owned fund, Glenview Capital in its recent 13F filing disclosed newly acquired stakes in Valvoline (VVV) with 1.7M shares, Berkeley Lights (BLI) with 1.19M shares, Las Vegas Sands (LVS) with 1M shares, Meta Platforms (FB) with 0.08M shares. The fund exited posi...
Rapid Micro Biosystems Inc. (RPID) Q1 2022 Earnings Conference Call May 10, 2022 8:30 AM ET Company Participants Michael Beaulieu - CFA Vice President, Investor Relations and Corporate Communications Robert Spignesi - President and Chief Executive Officer Sean Wirtjes - Chief Financial Office...
Image source: The Motley Fool. Rapid Micro Biosystems, Inc. (NASDAQ: RPID) Q1 2022 Earnings Call May 10, 2022 , 8:30 a.m. ET Operator Continue reading For further details see: Rapid Micro Biosystems, Inc. (RPID) Q1 2022 Earnings Call Tran...
Rapid Micro Biosystems press release (NASDAQ:RPID): Q1 GAAP EPS of -$0.35 misses by $0.01. Revenue of $4.16M (-16.6% Y/Y) misses by $0.99M. Full Year 2022 Outlook: The Company is reaffirming its prior full year 2022 outlook for revenue of between $27 million and $32 million vs consensus ...
Reports first quarter 2022 commercial revenue of $4.2 million Reaffirms full year 2022 commercial revenue outlook range of $27 million to $32 million, representing growth of approximately 25% to 50% LOWELL, Mass., May 10, 2022 (GLOBE NEWSWIRE) -- Rapid Micro Biosys...
LOWELL, Mass., April 26, 2022 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of hea...
Gainers: Eiger BioPharmaceuticals (EIGR) +36%. Cyteir Therapeutics (CYT) +30%. PAVmed (PAVM) +28%. Cingulate (CING) +26%. Bone Biologics (OTCPK:BBLG) +22%. Losers: Incannex Healthcare Limited (IXHL) -12%. Jounce Therapeutics (JNCE) -9%. Rapid Micro Biosystems (RPID) -...
News, Short Squeeze, Breakout and More Instantly...
Rapid Micro Biosystems Inc. Company Name:
RPID Stock Symbol:
NASDAQ Market:
Rapid Micro Biosystems Inc. Website:
LOWELL, Mass., July 17, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare...
Commercial National Financial Corp. (CNAF) is expected to report for Q1 2024 First National Bank Alaska (FBAK) is expected to report for Q1 2024 Cyxtera Technologies Inc. (CYXTQ) is expected to report for quarter end 2024-03-31 Brookfield Renewable Corporation Class A Subordinate (BEP...